Sumitomo Chemical India Ltd. · NSE:SUMICHEM
Sumitomo Chemical India — Q3 FY2021 Earnings Presentation
38 slides from Sumitomo Chemical India's earnings presentation, February 2021
Slide 1: Sumitomo Chemical India Limited Investor Presentation
Sumitomo Chemical India Limited Investor Presentation February 2021
Slide 2: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sumitomo Chemical India Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 3: Financial Performance & Key Highlights
Financial Performance & Key Highlights 3
Slide 4: Performance Highlights – Quarter & YTD
Performance Highlights – Quarter & YTD Revenue (Rs Crs) Gross Profit (Rs. Crs) & EBITDA (Rs. Crs) & PAT (Rs Crs) Gross Profit Margin (%) EBITDA Margin (%) +26% +70% +7,770% +7% Quarter 211 78 54 561 523 167 46 37.6% 31.9% 13.9% 8.8% 1 9.7% Q3FY20 Q3FY21 Q3FY20 Q3FY21 Q3FY20 Q3FY21 0.1% Q3FY20* Q3FY2
Slide 5: Performance Highlights – YTD
Performance Highlights – YTD Key Highlights ✓ Covid-19 related lockdown ▪ Production lost during few initial weeks of the year ▪ Subsequently production resumed and ramped up gradually over the period ✓ Lower Inventory as on March 2020 (as compared March 2019) impacted sales in Q1 FY21 ✓ Focus on co
Slide 6: Consolidated Profit & Loss Account Statement – Quarter & YTD
Consolidated Profit & Loss Account Statement – Quarter & YTD Quarter YTD Particulars (Rs. Crs) Q3 FY21 Q3 FY20 YoY 9M FY21 9M FY20 YoY Revenue from Operations 560.9 523.1 7% 2,110.6 1,978.0 7% COGS 349.9 356.3 1,314.4 1,317.7 Gross Profit 211.1 166.8 26% 796.2 660.3 21% Gross Profit % 37.6% 31.9% 57
Slide 7: Revenue Breakup – YTD
Revenue Breakup – YTD Product Breakup Geographic Breakup 6% 6% 2% 3% 3% 2% 1% 0% 11% 11% 3% 1% 4% 2% 4% 3% 3% 7% 6% 47% 45% 9M FY20 9M FY21 9M FY20 9M FY21 11% 12% 18% 20% 84% 85% Insecticides PGR Fungicides Domestic Japan Europe North America Herbicides Metal Phosphides AND & EHD* Africa Asia (Ex.
Slide 8: Consolidated Working Capital Movement
Consolidated Working Capital Movement Change Change Particulars (Rs. Crs) Dec-20* Mar-20* (Dec-20 to Dec-19* (Dec-20 to Mar-20) Dec-19) Inventory (A) 544.0 588.0 -44.0 491.7 52.3 Inventory Days (Inventories/ COGS* No. of days in period) (i) 143 134 127 Trade Receivables (B) 916.5 849.8 66.7 981.7 -6
Slide 9: Sumitomo Chemical Company Limited, Japan – An Introduction
Sumitomo Chemical Company Limited, Japan - An Introduction
Slide 10: Overview of our Parent Company
Overview of our Parent Company About Sumitomo ✓ Sumitomo started business in Japan in early 16th Century (400 years+) ✓ Currently several Sumitomo founded companies operate as independent listed companies with widespread shareholding and run by its professional boards ✓ Even today, all Sumitomo comp
Slide 11: SCC - Growth Strategy in Health & Crop Sciences Sector - R&D
SCC - Growth Strategy in Health & Crop Sciences Sector - R&D Core Competence: R&D R&D performance data (Million US$) Crop Protection Sales & Number of Issued Patent (2012-2019) Sumitomo Chemical is conducting 14,000 12,600 Crop Protection Products Sales Numbers of Issued Patents R&D based on the kno
Slide 12: SCC - Growth Strategy in Health & Crop Sciences Sector - Distribution
SCC - Growth Strategy in Health & Crop Sciences Sector - Distribution Refer SCC, Japan IR presentation and Investor handbook 2020 at SCC website 12
Slide 13: Sumitomo Chemical India Ltd. – Company Overview
Sumitomo Chemical India Ltd., - Company Overview Journey to 10x Growth Formidable Player in the Indian SCIL - Vision & Mission in India Agrochemicals Space Diversified & De-risked Portfolio Strong Brand and Well- Strategically Located Across the Agro-Chem Value Entrenched Distribution Manufacturing
Slide 14: SCIL - Vision & Mission
SCIL - Vision & Mission Vision & Values Mission Vision: Marketing and Sales: • To be a trusted market leader in Indian crop- • Further penetration into Indian market & take protection sector leadership; expand exports • To develop a vibrant corporate culture • Strengthen Sales Force, Distribution an
Slide 15: Journey to 10x Growth in India
Journey to 10x Growth in India Exploration Phase: 2000 – 2009 Manufacturing JV with New Acquired product - 2000 Chemi 2002 Started EHD (Public Health) 2005 ‘Sulfosulfuron’ Leader 2010 business rights from Monsanto Started Animal Nutrition SCIL incorporated in India as 2001 Started ASD business 2003
Slide 16: Formidable Player in the Indian Agrochemicals Space
Formidable Player in the Indian Agrochemicals Space 5 190+ Grown 10X+* over FY11-20 Manufacturing Brands Rs. Bn Facilities 10X 24 10+ 25+ / 200+ Technical Actives Patents / Registrations 13,000+ 1,500+ Distributors Employees Product Name Product Category Indicative Use Glyphosate Herbicide Tea Garde
Slide 17: Diversified & De-risked Portfolio Across the Agro-Chem Value Chain
Diversified & De-risked Portfolio Across the Agro-Chem Value Chain Well-Diversified across multiple dimensions Business Products Geographies Customers Crops Served Segments Diversified Portfolio Across Segments Geographic Diversification with Exports to over 60 countries Generics Speciality 7% 4% No
Slide 18: Strong Brand and Well-Entrenched Distribution Network
Strong Brand and Well-Entrenched Distribution Network ✓ Strong brand with market leading position across various product categories 23 States 65+ Depots ✓ Dual brand portfolio can offer products at all price points serving multiple customer sub-segments 13,000+ ~40,000 ✓ In-depth knowledge of own re
Slide 19: Expanding Brand Visibility and Connect
Expanding Brand Visibility and Connect ✓ Wide range of generics and speciality products for Increased crop presence and providing crop protection solutions ✓ More than 1,400+ Relationship managers connecting to 1 million+ farmers throughout crop cycle ✓ Over 100 brands covering maximum of crops and
Slide 20: Digital Marketing Initiatives
Digital Marketing Initiatives Develop “Digital Marketing” as a parallel support to Traditional marketing system leading to improved sales. ✓ Our Digital Assets : 21 websites, currently driving about 8,648 visitors everyday. YouTube - Advantage http://www.danitolindia.com/ http://www.naturedeep.in/ I
Slide 21: Strategically Located Manufacturing Facilities
Strategically Located Manufacturing Facilities Connectivity to Major Cities and Proximity to Main Highways, Ports Reduces Logistic Time and Costs Plant Location Area (acres) Segment Served Product Manufactured Manufacturing of Technical Grade Pesticides Technical Grade Products: Bhavnagar ~58 and Fo
Slide 22: Strong Focus on R&D and Process Innovation
Strong Focus on R&D and Process Innovation End-to-End Product Development Capabilities ✓ 3 fully equipped, DSIR approved R&D labs located at Mumbai, Bhavnagar and Gajod capable of synthesis, technical product and formulation development ✓ R&D Team comprises of 75+ qualified and dedicated engineers &
Slide 23: Thrust on Safety, Health and Environment (SHE)
Thrust on Safety, Health and Environment (SHE) Quality Certifications Ensure Consistent product quality and healthy working environment at manufacturing sites Abiding by SCC Japan’s EHS Policies ISO:9001:2015, ISO-14001:2015 and OHSAS18001:2007 for the manufacturing sites at Bhavnagar, Gajod, Tarapu
Slide 24: Autonomous Board with Vast Industry Experience
Autonomous Board with Vast Industry Experience Dr. Mukul Govindji Asher Preeti Gautam Mehta Chairman and Independent Director Independent Non-executive Director ▪ Professorial Fellow at Lee Kuan Yew School of Public Policy at ▪ 30 years of experience in corporate laws, foreign investment the Nationa
Slide 25: Autonomous Board with Vast Industry Experience
Autonomous Board with Vast Industry Experience Hiroyoshi Mukai Tadashi Katayama Masanori Uzawa Non-executive Director Non-executive Director Non-executive Director ▪ MBA from University of Virginia, USA and ▪ MBA from Vanderbilt University, U.S.A. a Bachelor’s degree from the University ▪ Associated
Slide 26: Growth Strategies
Growth Strategies Continued Investment in R&D and Pipeline Capacity Expansion Achieving Market Leadership in • Aim to invest in seamless integration of R&D between SCIL and SCC • units which would help improve our production processes, Driving operational efficiencies maintaining highest safety stan
Slide 27: Financial Performance & Key Takeaways
Historical Performance Highlights Financial Performance & Key Takeaways Key Takeaways
Slide 28: Historical Performance Highlights
Historical Performance Highlights Revenue (Rs Crs) EBITDA (Rs. Crs) & EBITDA Margin (%) PAT (Rs Crs) ✓ Good monsoon and availability +13% +24% of water boosted farmer +19% 2,425 333 205 sentiment and resulted in good 2,228 291 1,913 166 growth in rabi season 2019 as 217 145 well as upcoming Kharif s
Slide 29: Consolidated Profit & Loss Account Statement
Consolidated Profit & Loss Account Statement Particulars (Rs. Crs) H1 FY21 FY20 FY19 FY18 Net Revenue from Operations 1,549.7 2,424.8 2,228.4 1,912.9* COGS 964.6 1,607.6 1,458.9 1,238.7 Gross Profit 585.1 817.2 769.6 674.2 Gross Profit % 37.8% 33.7% 34.5% 35.2% Employee Expenses 102.4 179.3 158.4 14
Slide 30: Consolidated Balance Sheet
Consolidated Balance Sheet Assets (Rs. Crs) Sep-20 Mar-20 Mar-19 Mar-18 Equity & Liabilities (Rs. Crs) Sep-20 Mar-20 Mar-19 Mar-18 Non-Current Assets (A) 361.3 360.6 318.3 312.7 EQUITY (A) 1,429.6 1,221.8 1,048.4 954.0 Property, Plant and Equipment 278.8 282.9 277.2 264.8 Equity Share Capital 499.1
Slide 31: Consolidated Working Capital Movement
Consolidated Working Capital Movement Particulars (Rs. Crs) Mar-20 Mar-19 Change Inventory (A) 588.0 680.6 -92.6 Inventory Days (Inventories/ COGS*365) (i) 133 170 Trade Receivables (B) 849.8 671.0 178.8 Trade Receivables Days (Trade Receivables / Revenue*365) (ii) 128 110 Trade Payables (C) 490.9 4
Slide 32: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Half year ended Cash Flow Statement (Rs. Crs) Mar-20 Mar-19 Mar-18 30-Sep-20 Net Profit Before Tax 321.0 266.5 259.8 221.0 Adjustments for: Non-Cash Items / Other Investment or Financial Items 30.2 45.7 18.6 9.6 Operating profit before working capital changes 351.2 3
Slide 33: Key Takeaways
Key Takeaways Formidable Player in the Indian Experienced Management Team Well-diversified Product Portfolio Strong Brand and Well-Entrenched Agro-chem Space and Board of Directors Across Agro-Chem Value Chain Distribution Network ▪ Strong / leadership position across ▪ Strong management and ▪ Multi
Slide 34: Annexures
Awards & Accolades Annexures Details on Merger with Excel Crop Care Ltd. Sector Tailwinds
Slide 35: Awards & Accolades
Awards & Accolades Jamnalal Bajaj Award for “Fair Business and Practices” Shramveer award for improvement of product efficiency received from national level Delhi First ever president’s gold shield for import substitution Vishwakarma Rashtriya Puraskar received for process development First award fo
Slide 36: Merger of Excel Crop Care to Unlock Value
Merger of Excel Crop Care to Unlock Value Successfully and smoothly completed the merger Pre-Merger Structure Post-Merger Structure SCC and its affiliates Public Shareholders SCC and its affiliates (Japan) 44.98% Public & Others (Japan) 35.03% Excel Crop Care (ECC) 75% 19.7% 100.00% 19.98% Sumitomo
Slide 37: Well Placed to Benefit from Sector Tailwinds
Well Placed to Benefit from Sector Tailwinds Pesticides: Market Share by Segment Highly Underpenetrated Market Significant growth opportunity for Indian Players 5% Pesticide Consumption (Kg/ha) Agrochemical Market Size (US$ bn) 1% 22% 13 12 +8% 8.1 FY18 47% 7 4.1 5 5 25% <1 Insecticides PGR Fungicid
Slide 38: For further information, please contact
For further information, please contact: Company : Investor Relations Advisors : Sumitomo Chemical India Limited Strategic Growth Advisors Pvt. Ltd. CIN: L24110MH2000PLC124224 CIN: U74140MH2010PTC204285 Mr. Jigar Kavaiya +91 99206 02034 investor.relations@sumichem.co.in jigar.kavaiya@sgapl.net www.s
Sumitomo Chemical India — Q3 FY2021 Earnings Presentation on 6ix